Subscribe to ExpertReview

The latest research, meeting updates and CME, in your inbox.

Hong Kong · Sponsored

COVID-19 Vaccine Safety and Effectiveness for the Elderly with Comorbidities

17 May 2022

Connie TANG

Share

This content is sponsored. It is intended for healthcare professionals only.

In a recent symposium held on 6 April 2022, Dr Chan Fei, a specialist in Geriatric Medicine, shared the clinical and real world data of the mRNA and inactivated vaccines available in Hong Kong and expert opinions on the elderly receiving vaccinations.

COVID-19 Vaccine Safety and Effectiveness for the Elderly with Comorbidities

For healthcare professionals

This sponsored content is for registered Hong Kong doctors. Log in or register to read it. If you received an access link, open it from your email.

Log inRegister

Related posts

Stylized illustration of a large blue immune cell with surface receptors and yellow nuclei, surrounded by smaller cells.Research · OncologyESCAT v2 adds graded certainty tiers and a resistance scale for molecular targetsAn international ESMO expert panel has revised the 2018 ESCAT framework, restructuring Tier I, Tier II and Tier X, formalising tumour-agnostic gating criteria and adding a four-level scale for resistance biomarkers.8 Nov 2026